Market commentary Fighting with both hands

China's National Party Congress (NPC) meeting has major implications for investors.

13 Oct 2017

China's National Party Congress (NPC) meeting has major implications for investors. Xi Jinping's stronger power base following the NPC means he will fight with both hands on an agenda that will prolong China's mini-cyclical slowdown but create attractive opportunities.

Xi Jinping: China's strongest leader since Deng Xiaoping

Xi Jinping has emerged from the NPC meeting as China's strongest leader since Deng Xiaoping with his political thought enshrined in the Party's constitution and allies occupying senior positions in all levels of government. This marks a change from when Xi first took power in 2012. At that time, past leaders' protégés occupied the majority of the senior positions in the Party. Now, Xi and his allies dominate the Party and its most senior decision-making body, making up four of the seven members on the Politburo Standing Committee.

Xi's strengthened support base and elevated position means he has a freer rein and stronger resolve to execute the agenda he laid out in his opening speech on October 18th, which includes pushing reforms, controlling financial risks, regulating the real estate market, and protecting the environment.

Dropping the 'Presidential Put'

Tellingly, Xi omitted an explicit growth target for the economy in his speech, and that signals a different approach to managing the economy. Successive Chinese leaders have focused on meeting defined growth targets, making China observers accustomed to the Chinese 'presidential put' - an unofficial guarantee of government credit support to achieve the growth number, often at the expense of the economy's longer term health.

In line with our earlier predictions1, Xi's speech indicates that this 'presidential put' has been tossed aside and he now has the power and the political capital to weather slower growth and shift the focus of government policy toward reforms that improve the long-term growth potential of the economy.

Shifting the focus of government policy

That's why environmental issues are coming to the fore. Pollution is an increasingly sensitive issue for the public and one the government is now taking seriously, with centrally sponsored inspection teams scouring the country to spot-check local officials and enterprises and force them to shut outdated, polluting factories and comply with new environmental standards.

Real estate policy, often used by the authorities as a tool to boost the economy in bad times, is also undergoing a change. Xi stressed that 'a house is for living in, not for speculation' in his speech and policy statements show that the government is increasingly focused on imposing new regulations, with rules barring speculation, as well as promoting rental market reforms and rolling back state-backed property buying being applied nationwide. This indicates that even with slower growth, a policy binge to support the market is off the table for 2018.

Deleveraging and China's mini-cyclical slowdown

In addition to the above factors, Xi's focus on pushing reform and containing financial risks means the deleveraging process that has tightened liquidity, increased money market rates, raised bond yields, and forced credit growth to contract since late-2016 will continue, and China Banking Regulatory Commission (CBRC) officials confirmed as much in the days following Xi's NPC speech2.

Xi's political reshuffling is aligning with this strategy too. Guo Shuqing - the reformist CBRC head and executor of the recent deleveraging campaign – is reportedly the most likely candidate3 to take over from the retiring Zhou Xiaochuan as Governor of the People's Bank of China. With Guo Shuqing in charge, we expect a tough line on the financial sector and an extension of the deleveraging process. These factors firm our expectation of a prolonged minicyclical slowdown through late-2017 and into 2018. Indeed, recent data shows weakening growth in real estate sales4 and private investment5, which we believe signals that a slowdown is underway.

Emerging markets to feel the impact in late-2017 and 2018

This marks a reverse from late-2016, when a rebound in China's economy boosted growth expectations, particularly in markets with strong linkages to China through commodity trade. That rebound drove higher Producer Price Index (PPI) readings, increased exports, and stronger fiscal balances, and supported upward earnings revisions for energy and mining companies.

Now that China is slowing, the key support for stronger growth expectations, particularly in emerging markets with substantial trade ties to China, has to be questioned. We believe the key to any investment strategy will be timing, given our expectation that emerging markets will feel the impact of China's slowdown in late-2017 and 2018.

Rising bond yields are a compelling opportunity for investors

While China's slowdown and the shift in the government's attitude change the outlook for emerging markets, it's also creating compelling opportunities for investors. The steady rise in domestic bond yields during the past year offers investors the opportunity to add longer-term maturities into their portfolio, particularly as current yields in the 3.75%6 range offer attractive value compared with fixed income opportunities globally and provide high nominal and real income and the potential for capital appreciation.

More insights

Singapore Retail Investors


This website is not intended for and should not be accessed by persons located or resident in any jurisdiction where (by reason of that person's nationality, domicile, residence or otherwise) the publication or availability of this website is prohibited or contrary to local law or regulation or would subject any UBS entity to any registration or licensing requirements in such jurisdictions. It is your responsibility to be aware of, to obtain all relevant regulatory approvals, licenses, verifications and/or registrations under, and to observe all applicable laws and regulations of any relevant jurisdiction in connection with your entrance to this website. Each investment product and service referred to on this website is intended to be made available only to residents in Singapore.

UBS reserves the right to change, modify, add or remove content on the website as well as these terms at any time for any reason without notice. Such changes shall be effective immediately upon posting. You acknowledge that by accessing our website after we have posted changes to these terms, you are agreeing to these terms as modified.

The materials on this Website are distributed by UBS Asset Management (Singapore) Ltd (company registration number: 199308367C), which is licensed by Monetary Authority of Singapore ("MAS") in Singapore pursuant to the Securities and Futures Act (Chapter 289 of Singapore). UBS Asset Management (Singapore) Ltd is part of the Asset Management business division of UBS Group AG. UBS Asset Management (Singapore) Ltd together with UBS Group AG and its group companies shall collectively be referred to as "UBS".

The information contained in this Website has been prepared and is intended for general circulation. The information does not constitute advice and does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. The investment services or products referred to in this Website may not be suitable for all investors. UBS recommends that you independently evaluate particular investments and strategies and seek independent advice from a financial adviser regarding the suitability of such investment products, taking into account your specific investment objectives, financial situation and particular needs, before making a commitment to purchase any investment products. Investment involves risks. You should be aware that investments may increase or decrease in value and that past performance is not indicative of future performance.

The information contained in this Website is not an offer to buy or sell or the solicitation of an offer to buy or sell any investment product or to participate in any particular trading strategy. UBS, its officers and/or employees may have interests in any of the investment products referred to on this Website by acting in various roles. UBS, its officers and/or employees may receive fees, commissions or other benefits for acting in those capacities. In addition, UBS, its officers and/or employees may buy or sell investment products as principal or agent and may effect transactions which are not consistent with the information set out in this Website.

You fully understand and agree that, by making available this Website, UBS should not be construed as making: (a) any endorsement of any investment product referred to in this Website; (b) any representation that UBS has performed any due diligence on any investment product referred to in this Website; or (c) any representation that the information in this Website is complete, accurate, clear, fair and not misleading. The use or reliance on any such information contained in this Website is at your own risk and any losses which may be suffered as a result of you entering into any investment are for your account and UBS shall not be liable for any losses arising from or incurred by you in connection therewith. UBS is not responsible or liable for the accuracy and completeness of any such information or the performance or outcome of any investment made by you after receipt of such information, irrespective of whether such information was provided at your request.

Using, copying, redistributing or republishing any part of this Website without prior written permission from UBS is prohibited. Any statements made regarding investment performance objectives, risk and/or return targets shall not constitute a representation or warranty that such objectives or expectations will be achieved or risks are fully disclosed. The information and opinions contained in this Website is based upon information obtained from sources believed to be reliable and in good faith but no responsibility is accepted for any misrepresentation, errors or omissions. All such information and opinions are subject to change without notice. A number of comments in this Website are based on current expectations and are considered “forward-looking statements”. Actual future results may prove to be different from expectations and any unforeseen risk or event may arise in the future. The opinions expressed are a reflection of UBS’s judgment at the time this document is compiled and any obligation to update or alter forward-looking statements as a result of new information, future events, or otherwise is disclaimed.

UBS does not hold out any of its officers and/or employees as having any authority to advise you, and UBS does not purport to advise you on any investment product. Any investment will be made at your sole risk and UBS is not and shall not, in any manner, be liable or responsible for the consequences of any investment.

This Website and its contents are provided on an “as is” and “as available” basis. UBS does not warrant: (a) the accuracy, timeliness, adequacy commercial value or completeness of this Website or its contents, and expressly disclaims any liability for errors, delays or omissions in the contents, or for any action taken in reliance on the contents; (b) that your use of and/or access to this Website or its contents, will be uninterrupted, timely, secure or free from errors or that any identified defect will be corrected; (c) that this Website or any content will meet your requirements or are free from any virus or other malicious, destructive or corrupting code, agent, program or macros; (d) that any information, instructions or communications posted or transmitted by you through this Website is secure and cannot be accessed by unauthorised third parties; and (e) that use of the contents in this Website by you will not infringe the rights of any third parties. No warranty of any kind, implied, express or statutory, including but not limited to the warranties of non-infringement of third party rights, title, merchantability, satisfactory quality or fitness for a particular purpose and freedom from computer virus or other malicious, destructive or corrupting code, agent, program or macros, is given in conjunction with this Website.

You hereby agree to indemnify UBS and any of its officers, employees or agents against, and to keep UBS and any of its officers, employees or agents harmless from, any claims (actual and threatened), settlement sums, liability, loss, damages, costs (including solicitor and client costs and expenses (legal or otherwise)), charges, expenses, actions, proceedings, whether foreseeable or not which we may sustain, suffer or incur, directly or indirectly out of or in the course of or in connection with any the following: (a) any use of this Website or the contents by you, or any part thereof; (b) UBS having made available the Website; (c) any breach of these Terms by you, however arising; or (d) any negligence, act or omission, wilful default, unlawful act, fraud and/or misconduct on your part or violation of any rights of another person or entity by you.

The funds referred to in this Website have been authorised or recognised by the MAS for sale to the public in Singapore (the “Funds”). Copies of the registered Singapore prospectuses ("Prospectuses") referred to in this Website have been lodged with and registered by the MAS. The MAS assumes no responsibility for the contents of the Prospectuses. The registration of the Prospectuses by the MAS does not imply that the SFA or any other legal or regulatory requirements have been complied with.

MAS registration is not a recommendation or endorsement of a Fund nor does it guarantee the commercial merits or performance of such Fund. It does not mean that a Fund is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. UBS Asset Management (Singapore) Ltd has been appointed as the representative for the Funds in Singapore for the purposes of performing administrative and other related functions relating to the offer of Shares under Section 287 of the Securities and Futures Act, Chapter 289 of Singapore (the "SFA") and such other functions as the MAS may prescribe.

You may not assign your rights under the Terms without our prior written consent. UBS Asset Management (Singapore) Ltd may assign our rights under the Terms to any third party.

No person or entity who is not a party to the Terms shall have any right under the Contracts (Rights of Third Parties) Act, Chapter 53B of Singapore or other similar laws to enforce any term of the Terms regardless of whether such person or entity has been identified by name, as a member of a class or as answering a particular description. For the avoidance of doubt, this shall not affect the rights of any permitted assignee or transferee of the Terms.

These Terms shall be governed by, and shall be construed in accordance with, the laws of Singapore. The courts of Singapore shall have exclusive jurisdiction to hear and determine any suit, action or proceeding, and to settle any disputes, which may arise out of or in connection with these Terms and, for such purposes, you agree to submit  to the jurisdiction of the courts of Singapore. Each party hereby waives any objection which it might at any time have to the courts of Singapore being nominated as the forum to hear and determine any proceedings and to settle any disputes and agrees not to claim that the courts of Singapore are not a convenient or appropriate forum.

© UBS 2020 - the key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.